Skip to main content
OpenTrials

Clinical trial condition

Non-squamous NSCLC

Explore clinical trials studying Non-squamous NSCLC. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Non-squamous NSCLC trial results

Completed

Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

NCT04447118

Conditions
HER2 Exon 20 Mutation, Non-squamous NSCLC
Locations
  • University of California - Irvine Medical Center Orange, California, United States
  • University of California (UC) Davis Comprehensive Cancer Center Sacramento, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Florida Cancer Specialists South Divisio Fort Myers, Florida, United States
View all 102 locations
View Trial Details
Active, Not Recruiting

AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC

NCT04413201

Conditions
Non-squamous NSCLC
Locations
  • Klinikum der Ludwig-Maximilians-Universität München München, Bavaria, Germany
  • Universitätsklinikum Gießen Marburg Giessen, Hesse, Germany
  • Sana-Klinikum Offenbach Offenbach, Hesse, Germany
  • Evangelische Lungenklinik Berlin Berlin, Germany
View Trial Details

Related conditions